{
    "clinical_study": {
        "@rank": "63858", 
        "arm_group": {
            "arm_group_label": "toll like receptor (TLRs)", 
            "arm_group_type": "Experimental", 
            "description": "TLRs are a family of proteins responsible for the recognition of Pathogen-Associated Molecular Patters"
        }, 
        "brief_summary": {
            "textblock": "Introduction: Recently it has involved the role of TLR (toll-like receptors) in the\n      pathogenesis of asthma. TLRs are a family of proteins responsible for the recognition of\n      Pathogen-Associated Molecular Patters (PAMPs). The possible role that TLRs play in\n      IgE-dependent asthma (not eosinophilic) and its recognition as a new endotype asthma, could\n      open new therapeutic expectations.\n\n      Objective: To analyze the expression of TLR 2 and 4 in monocytes/ macrophages and\n      neutrophils in peripheral blood and induced sputum from asthmatic patients"
        }, 
        "brief_title": "Expression of Toll-Like Receptors 2 and 4 in Asthmatic Patients.", 
        "completion_date": {
            "#text": "September 2013", 
            "@type": "Actual"
        }, 
        "condition": "Asthma", 
        "condition_browse": {
            "mesh_term": "Asthma"
        }, 
        "detailed_description": {
            "textblock": "The investigators studied patients with asthma.  All patients underwent the same day an\n      induced sputum, pulmonary function studies, fractional exhaled nitric oxide, blood total IgE\n      and skin test by prick technique. Asthmatic patients were classified according to the\n      criteria of the GINA 2012. The cellular composition was analyzed by flow cytometry.\n      Expression of TLR2 and TLR4 were analyzed using monoclonal antibodies conjugated with\n      fluorochromes appropriate."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Adults with persistent asthma (defined as per the Global INitiative for Asthma\n             Management (GINA) criteria)\n\n        Exclusion Criteria:\n\n          -  If they had a respiratory tract infection or asthma exacerbation within 30 days prior\n             to inclusion\n\n          -  If they were receiving oral steroids or immunosuppressive treatments."
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "80 Years", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "59", 
            "@type": "Actual"
        }, 
        "firstreceived_date": "January 3, 2014", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT02028637", 
            "org_study_id": "43/2009"
        }, 
        "intervention": {
            "arm_group_label": "toll like receptor (TLRs)", 
            "description": "Recently it has involved the role of TLR (toll-like receptors) in the pathogenesis of asthma.The possible role that TLRs play in the asthma and its recognition as a new endotype asthma, could open new therapeutic expectations.", 
            "intervention_name": "TLRs", 
            "intervention_type": "Other", 
            "other_name": "TLRs"
        }, 
        "is_fda_regulated": "No", 
        "keyword": [
            "asthma", 
            "toll like receptor", 
            "innate immunity"
        ], 
        "lastchanged_date": "January 4, 2014", 
        "link": {
            "description": "Asthma", 
            "url": "http://www.ginasthma.org/."
        }, 
        "location": {
            "facility": {
                "address": {
                    "city": "Barcelona", 
                    "country": "Spain", 
                    "zip": "08025"
                }, 
                "name": "Hospital de la Santa Creu i Sant Pau"
            }
        }, 
        "location_countries": {
            "country": "Spain"
        }, 
        "number_of_arms": "1", 
        "official_title": "Expression of Toll-Like Receptors 2 and 4 in Asthmatic Patients.", 
        "overall_official": {
            "affiliation": "Department of Respiratory Medicine, Hospital de la Santa Creu i Sant Pau. Institut d'Investigaci\u00f3 Biom\u00e9dica Sant Pau (IIB Sant Pau). Universitat Aut\u00f2noma de Barcelona, Department of Medicine.", 
            "last_name": "Astrid Crespo", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Completed", 
        "oversight_info": {
            "authority": "Spain: Comit\u00e9 \u00c9tico de Investigaci\u00f3n Cl\u00ednica", 
            "has_dmc": "Yes"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "September 2013", 
            "@type": "Actual"
        }, 
        "primary_outcome": {
            "description": "The percentage of neutrophils expressing TLR4 in induced sputum decreases in asthma not eosinophilic (IgEnodep).This could suggest that in this type of asthma the defense mechanism of neutrophils could be altered by decreasing expression of these receptors on their cell surface. This mechanism would still be defined. Probably the respiratory infections play an important role.", 
            "measure": "The percentage of neutrophils expressing TLR4 in induced sputum decreases in asthma not eosinophilic", 
            "safety_issue": "Yes", 
            "time_frame": "2 years"
        }, 
        "reference": [
            {
                "PMID": "14516137", 
                "citation": "The ENFUMOSA cross-sectional European multicentre study of the clinical phenotype of chronic severe asthma. European Network for Understanding Mechanisms of Severe Asthma. Eur Respir J. 2003 Sep;22(3):470-7."
            }, 
            {
                "PMID": "18805339", 
                "citation": "Anderson GP. Endotyping asthma: new insights into key pathogenic mechanisms in a complex, heterogeneous disease. Lancet. 2008 Sep 20;372(9643):1107-19. doi: 10.1016/S0140-6736(08)61452-X. Review."
            }, 
            {
                "PMID": "12239263", 
                "citation": "Weiss ST. Eat dirt--the hygiene hypothesis and allergic diseases. N Engl J Med. 2002 Sep 19;347(12):930-1."
            }, 
            {
                "PMID": "18209505", 
                "citation": "Gon Y. Toll-like receptors and airway inflammation. Allergol Int. 2008 Mar;57(1):33-7. doi: 10.2332/allergolint.R-07-157. Epub 2008 Mar 1. Review."
            }, 
            {
                "PMID": "16844729", 
                "citation": "Simpson JL, Grissell TV, Douwes J, Scott RJ, Boyle MJ, Gibson PG. Innate immune activation in neutrophilic asthma and bronchiectasis. Thorax. 2007 Mar;62(3):211-8. Epub 2006 Jul 14."
            }, 
            {
                "PMID": "19765883", 
                "citation": "Crespo-Lessmann A, Ju\u00e1rez-Rubio C, Plaza-Moral V. [Role of toll-like receptors in respiratory diseases]. Arch Bronconeumol. 2010 Mar;46(3):135-42. doi: 10.1016/j.arbres.2009.07.011. Epub 2009 Sep 17. Review. Spanish."
            }, 
            {
                "PMID": "22204819", 
                "citation": "Vidal S, Bellido-Casado J, Granel C, Crespo A, Plaza V, Ju\u00e1rez C. Flow cytometry analysis of leukocytes in induced sputum from asthmatic patients. Immunobiology. 2012 Jul;217(7):692-7. doi: 10.1016/j.imbio.2011.11.008. Epub 2011 Dec 2."
            }
        ], 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT02028637"
        }, 
        "responsible_party": {
            "investigator_affiliation": "Fundaci\u00f3 Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau", 
            "investigator_full_name": "Astrid Crespo", 
            "investigator_title": "Department of Respiratory Medicine, Hospital de la Santa Creu i Sant Pau. Institut d'Investigaci\u00f3 Biom\u00e9dica Sant Pau (IIB Sant Pau). Universitat Aut\u00f2noma de Barcelona, Department of Medicine. Barcelona Respiratory Network (BRN). Barcelona, Spain.", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "source": "Fundaci\u00f3 Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Fundaci\u00f3 Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "July 2009", 
        "study_design": "Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Basic Science", 
        "study_type": "Interventional", 
        "verification_date": "January 2014"
    }
}